[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100554538":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":25,"locations":35,"responsibleParty":52,"collaborators":24,"id":54,"slug":24,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":24,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":24,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":74,"overallStatus":37,"whyStopped":24,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Marmara University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group of patients using levonorgestrel intrauterine system","EXPERIMENTAL","The levonorgestrel intrauterine system use patients group consisted of 50 women who had previously a mirena implanted by a gynecologist at least 3 months ago due to menstrual bleeding and pelvic pain.",[13],"Diagnostic Test: Examination of temporomandibular joint and masticator muscles",{"label":15,"type":10,"description":16,"interventionNames":17},"Control group of healthy patients","The control group included 50 randomized health women who had regular menstrual cycles and were not taking any medication.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DIAGNOSTIC_TEST","Examination of temporomandibular joint and masticator muscles","The TMJ and the masticatory muscles were evaluated by the same clinician. Patients described symptoms such as preauricular pain, limited mouth opening, deviation or deflection during mouth opening, and joint sounds. All patients were assessed using Okeson's Muscle and temporomandibular joint examination and treatment outcome form. This form records (for both TMJ) tenderness and pain in the masseter, temporalis, lateral pterygoid, medial pterygoid, sternocleidomastoid, trapezius, splenius capitis, and digastric muscles, as well as maximum interincisal distance, restriction of laterotrusion and protrusive movements, joint sounds, deviation or deflection during mouth opening, and the visual analogue score (VAS) for pain in the TMJ.",[15,9],null,[26,31],{"name":27,"role":28,"phone":29,"phoneExt":24,"email":30},"Serhat Can, Specialist","CONTACT","+905556161166","drserhatcan@gmail.com",{"name":32,"role":28,"phone":33,"phoneExt":24,"email":34},"Sinem Busra Kirac Can, Specialist","+905064181024","sb.kirac@gmail.com",[36],{"facility":5,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":24,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Istanbul","Maltepe","34854","Turkey (Türkiye)",{"type":43,"coordinates":44},"Point",[45,46],28.94966,41.01384,{"lat":46,"lon":45},[49],{"name":50,"role":28,"phone":51,"phoneExt":24,"email":34},"Sinem Busra Kirac Can","+902167775000",{"type":53,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100554538",false,"NCT06500390","Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System","Is the Incidence of Temporomandibular Disorder Increased in the Use of Levonorgestrel Intrauterine System","Inclusion Criteria:\n\n* Being a woman\n* Having used an intrauterine device for at least 3 months\n* Being between the ages of 18-50\n* Being in American Society of Anesthesiologists-1 and American Society of Anesthesiologists-2 systemic status\n\nExclusion Criteria:\n\n* Patients with craniofacial syndrome\n* Patients with a history of head and neck trauma\n* Isolated muscle tenderness or previous surgery on TMJ\n* Patients with rheumatological disorders\n* Patients with an additional gynecological disease other than endometriosis\n* Lack of cooperation with the patient.","FEMALE","18 Years","45 Years",{"count":64,"type":65},100,"ESTIMATED","INTERVENTIONAL",[68],"NA","The goal of this clinical trial is to investigate the possible role of levonorgestrel intrauterine system use(LIU) in the pathogenesis of temporomandibular joint disorder (TMD). In this clinical trial, levonorgestrel intrauterine system patients (n=30) aged 25-50 and control group patients (n=30) with the same demographics and age range are used. The main questions it aims to answer are:\n\nTo compare the frequency of temporomandibular dysfunction in women using the levonorgestrel intrauterine system with the control group of the same demographic and age range.\n\nThe levonorgestrel intrauterine system use group consisted of 50 women who had previously a mirena implanted by a gynecologist at least 3 months ago due to menstrual bleeding and pelvic pain.\n\nThe control group included 50 randomised healthy women who had regular menstrual cycles and were not taking any medication.",[71,72,73],"Levonorgestrel Adverse Reaction","Temporomandibular Joint Disorders","Temporomandibular Disorder",[75,76,77,78],"Mirena","Levonorgestrel","Intrauterine system","Temporomandibular disorder","2024-11-21",{"date":81,"type":82},"2024-11-25","ACTUAL",{"date":84,"type":82},"2024-01-15",{"date":86,"type":65},"2024-12-15",{"name":5,"class":6},1]